115 related articles for article (PubMed ID: 9632271)
1. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting.
Handgretinger R; Lang P; Schumm M; Taylor G; Neu S; Koscielnak E; Niethammer D; Klingebiel T
Bone Marrow Transplant; 1998 May; 21(10):987-93. PubMed ID: 9632271
[TBL] [Abstract][Full Text] [Related]
2. Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma.
Handgretinger R; Lang P; Ihm K; Schumm M; Geiselhart A; Koscielniak E; Hero B; Klingebiel T; Niethammer D
Bone Marrow Transplant; 2002 May; 29(9):731-6. PubMed ID: 12040469
[TBL] [Abstract][Full Text] [Related]
3. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
4. Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children.
Lang P; Schumm M; Taylor G; Klingebiel T; Neu S; Geiselhart A; Kuci S; Niethammer D; Handgretinger R
Bone Marrow Transplant; 1999 Sep; 24(6):583-9. PubMed ID: 10490722
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
6. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
7. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study.
Imai Y; Chou T; Tobinai K; Tanosaki R; Morishima Y; Ogura M; Shimazaki C; Taniwaki M; Hiraoka A; Tanimoto M; Koike T; Kogawa K; Hirai H; Yoshida T; Tamura K; Kishi K; Hotta T;
Bone Marrow Transplant; 2005 Mar; 35(5):479-87. PubMed ID: 15654349
[TBL] [Abstract][Full Text] [Related]
8. Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.
Di Nicola M; Siena S; Corradini P; Bregni M; Milanesi M; Magni M; Ruffini PA; Ravagnani F; Tarella C; Gianni AM
Bone Marrow Transplant; 1996 Dec; 18(6):1117-21. PubMed ID: 8971381
[TBL] [Abstract][Full Text] [Related]
9. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
[TBL] [Abstract][Full Text] [Related]
10. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
Rowley SD; Loken M; Radich J; Kunkle LA; Mills BJ; Gooley T; Holmberg L; McSweeney P; Beach K; MacLeod B; Appelbaum F; Bensinger WI
Bone Marrow Transplant; 1998 Jun; 21(12):1253-62. PubMed ID: 9674860
[TBL] [Abstract][Full Text] [Related]
11. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
Han X; Shi Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
[TBL] [Abstract][Full Text] [Related]
12. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
13. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
14. Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells.
Hoppe B; Mohr M; Roots-Weiss A; Kienast J; Berdel WE
Bone Marrow Transplant; 1999 Apr; 23(8):809-17. PubMed ID: 10231144
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
16. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ
Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
[TBL] [Abstract][Full Text] [Related]
17. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
18. Clinically applicable bulk isolation of blood CD34+ cells for autografting in children.
Kawano Y; Takaue Y; Law P; Watanabe T; Abe T; Okamoto Y; Makimoto A; Sato J; Nakagawa R; Kajiume T; Hirao A; Watanabe A; Kuroda Y
Bone Marrow Transplant; 1998 Nov; 22(10):1011-7. PubMed ID: 9849700
[TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
Abonour R; Scott KM; Kunkel LA; Robertson MJ; Hromas R; Graves V; Lazaridis EN; Cripe L; Gharpure V; Traycoff CM; Mills B; Srour EF; Cornetta K
Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692
[TBL] [Abstract][Full Text] [Related]
20. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
